NDC 42385-953 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC42385-953

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Laurus Labs Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA212114
Marketed since
July 26, 2019
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (2)

Package NDCDescriptionSince
42385-953-3030 TABLET, FILM COATED in 1 BOTTLE (42385-953-30)Jul 26, 2019
42385-953-9090 TABLET, FILM COATED in 1 BOTTLE (42385-953-90)Jul 26, 2019

Other Emtricitabine and tenofovir disoproxil fumarate products